Mardia Samyoung Capillary Tubes Company Limited announced the outcome of its Board of Directors meeting held on October 26, 2026. The board has approved the unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The company has also enclosed the Limited Review Report from its statutory auditors. The financial statements detail a net profit of ₹97.86 lakhs for the September quarter, compared to ₹105.06 lakhs in the previous quarter.
Board Approves Financial Results
Mardia Samyoung Capillary Tubes Company Limited has announced the approval of its unaudited standalone financial results for the second quarter and half-year ending September 30, 2026. The decision was made during the Board of Directors’ meeting held on October 26, 2026.
Key Financial Highlights (Q2 FY27)
The unaudited financial results for the quarter ended September 30, 2026, reveal a net profit of ₹97.86 lakhs. This figure represents a slight decrease from the net profit of ₹105.06 lakhs reported for the preceding quarter (June 30, 2026). The company reported total revenue from operations of ₹2,337.62 lakhs for the quarter.
Half-Yearly Performance
For the half-year ended September 30, 2026, the company’s net profit from continuing operations stood at ₹202.92 lakhs. The total revenue from operations for the half-year amounted to ₹4,821.53 lakhs. The accompanying documents include the Limited Review Report provided by the company’s statutory auditors, S K Bhavsar & Co., as per SEBI regulations.
Earning Per Share (EPS)
Basic Earnings Per Share (EPS) from continuing operations for the quarter ended September 30, 2026, was ₹0.12. Diluted EPS from continuing operations also stood at ₹0.12. For the half-year ended September 30, 2026, the basic and diluted EPS from continuing operations were both ₹0.26.
Source: BSE
